Malcisbo - the sweet vaccines company

Malcisbo develops novel carbohydrate-based vaccines for human & animal health. Based on a novel platform technology, we develop vaccines against bacterial and parasitic diseases.

Our development projects are:

Latest News

  • 29 February 2016

    Collaboration with a pharma company

    R&D collaboration with a pharma company targeting our Campylobacter vaccine.

  • 12 November 2015

    Parasite Glycobiology: A Bittersweet Symphony

    Publication in PLOS Pathogens


  • 23 September 2015

    Malcisbo at Glyco-Summer School in Braga, Portugal 23-25 September 2015

    Malcisbo has been invited to give a presentation on "Novel carbohydrate-based vaccines"